Stokes & Hubbell Capital Management’s Merck MRK Stock Holding History

Stokes & Hubbell Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$258K	Buy	3,248 +5	+0.2%	+$374	0.05%	120
2018 Q4	$236K	Sell	3,243 -292	-8%	-$20.6K	0.05%	115
2018 Q3	$239K	Buy	+3,535	New	+$225K	0.05%	118
2017 Q4	–	Sell	-3,533	Closed	-$216K	–	116
2017 Q3	$216K	Buy	3,533 +9	+0.3%	+$546	0.06%	111
2017 Q2	$216K	Buy	3,524 +8	+0.2%	+$487	0.07%	97
2017 Q1	$213K	Buy	+3,516	New	+$213K	0.07%	91
2016 Q4	–	Sell	-3,499	Closed	-$208K	–	91
2016 Q3	$208K	Buy	+3,499	New	+$205K	0.09%	82

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Stokes & Hubbell Capital Management's MRK Position: Q1 2019 in Review

Stokes & Hubbell Capital Management increased its Merck (MRK) stake by 0.15% in Q1 2019, buying an estimated $374 and bringing the position to 3,248 shares worth $258K. The position accounts for 0.05% of the portfolio, ranked #120.

Stokes & Hubbell Capital Management first reported a position in MRK in Q3 2016 and has held it in 7 quarters since. 2,293 funds tracked by Wall St. Rank hold MRK as of Q1 2019.

Stokes & Hubbell Capital Management held 3,248 shares of Merck worth $258K as of Q1 2019.
Stokes & Hubbell Capital Management bought 5 Merck shares in Q1 2019, an estimated $374.
Merck made up 0.05% of Stokes & Hubbell Capital Management's portfolio in Q1 2019, its #120 holding.
Stokes & Hubbell Capital Management first reported a position in Merck in Q3 2016 and has held it in 7 quarters since.
2,293 funds tracked by Wall St. Rank held Merck as of Q1 2019.

Based on Stokes & Hubbell Capital Management's 13F filing for Q1 2019, filed 24 Apr 2019.